| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.3 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.064 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.07 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |